Company Betapluspharm Srl with Fiscal Code 33041457
recorded a turnover of 2024 of
2.700,
with a net profit of
335
and having an average number of employees of
- .
The company operates in the field of Alte activităţi de servicii suport pentru întreprinderi n.c.a. having the NACE code 8299.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Betapluspharm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
18.824
18.305
13.868
882
87.215
86.774
113.850
42.089
27.431
2.700
Total Income - EUR
18.825
18.305
13.868
883
106.706
88.353
116.940
42.284
27.788
9.170
Total Expenses - EUR
12.752
12.655
18.896
39.819
97.566
77.820
75.089
44.569
45.580
8.673
Gross Profit/Loss - EUR
6.073
5.650
-5.028
-38.937
9.140
10.533
41.851
-2.284
-17.792
497
Net Profit/Loss - EUR
5.508
5.100
-5.413
-38.946
8.073
9.660
40.705
-2.705
-18.013
335
Employees
1
1
1
1
4
2
2
1
1
0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -90.1%, from 27.431 euro in the year 2023, to 2.700 euro in 2024.
The Net Profit increased by 335 euro, from 0 euro in 2023, to 335 in the last year.
Check the financial reports for the company - Betapluspharm Srl
Financial Rating - BETAPLUSPHARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Betapluspharm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Betapluspharm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Betapluspharm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
1.372 euro in 2024 which includes Inventories of
0 euro, Receivables of
1.358 euro and cash availability of
15 euro.
The company's Equity was valued at
-20.163 euro, while total Liabilities amounted to
23.681 euro.
Equity increased by 335 euro, from -20.613 euro in 2023, to -20.163 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Betapluspharm Srl